Logo

Proteome Systems, Prince Henry s Institute Medical Research to Co-Develop Ovarian Cancer Test

Oct 12, 2005

NEW YORK, Oct. 12 (GenomeWeb News) - Proteome Systems and Prince Henry's Institute Medical Research of Melbourne, Australia, plan to co-develop an early diagnostic for ovarian cancer, the Sydney-based company said today.

 

Proteome Systems brings several patented candidate markers to the partnership, while PHIMR contributes its technology in proteomics and reproductive biology, as well as its clinical expertise in ovarian cancer.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.